![](https://news.alnylam.com/sites/default/files/2020-06/ncom-hero_7.png)
A NEW CLASS OF MEDICINES
![](https://news.alnylam.com/sites/default/files/2019-05/believers.jpg)
Meet the Believers
Through countless meetings, clinical trial readouts, and red-eye flights, the Believers faced the optimism and the doubt head-on and made the choice to stand by the potential of RNAi therapeutics.
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site